new med for type 2 diabetes, Avandia (rosiglitazone)

July 1999

There's now a new med for type 2 diabetes, Avandia (rosiglitazone)...from SmithKline Beecham and Bristol-Myers Squibb.

It's a new "glitazone"...similar to Rezulin (troglitazone). A third one, Actos (pioglitazone) will be out later this summer.

All three lower blood glucose by improving insulin sensitivity.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote